_id

69104d02ccc777a4e85d52b4

Ticker

CGEM

Name

Cullinan Oncology LLC

Exchange

NASDAQ

Address

One Main Street, Cambridge, MA, United States, 02142

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://cullinantherapeutics.com

Description

Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States. The company develops zipalertinib, a bioavailable small molecule in Phase 3 trial for the treatment of patients with non-small cell lung cancer; CLN-978, a T cell engager to treat systemic lupus erythematosus and rheumatoid arthritis; and CLN-619, a monoclonal antibody in Phase 1 trial for the treatment of solid tumors and multiple myeloma. Its development products also include CLN-049, a humanized bispecific antibody in Phase 1 trial for the treatment of acute myeloid leukemia (AML) or myelodysplastic syndrome, as well as measurable residual disease positive AML; and CLN-617, a fusion protein in Phase 1 trial for the treatment of solid tumors. It has a collaboration agreement with Adimab, LLC to discover and/or optimize antibodies; and co-development agreement with Taiho Pharmaceutical Co., Ltd to develop zipalertinib. The company was formerly known as Cullinan Oncology, Inc. and changed its name to Cullinan Therapeutics, Inc. in April 2024. Cullinan Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Last Close

12.38

Volume

612130

Current Price

11.92

Change

-3.7156704361874056

Last Updated

2025-11-29T11:22:22.073Z

Image

-

Ipo Date

2021-01-08T00:00:00.000Z

Market Cap

671697088

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9810399999999999

Sentiment Sources

5

Rating

4.8889

Target Price

27

Strong Buy

8

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

55595000

Operating Income

-55595000

Interest Expense

-

Pretax Income

-50610000

Net Income

-50610000

Eps

-0.8575785817165128

Dividends Per Share

-

Shares Outstanding

59076259

Income Tax Expense

-

EBITDA

-50531000

Operating Margin

-

Total Other Income Expense Net

4985000

Cash

103335000

Short Term Investments

229261000

Receivables

-

Inventories

-

Total Current Assets

342235000

Property Plant Equipment

1535000

Total Assets

484126000

Payables

1722000

Short Term Debt

1188000

Long Term Debt

-

Total Liabilities

32757000

Equity

451369000

Depreciation

79000

Change In Working Capital

5545000

Cash From Operations

-36877000

Capital Expenditures

36877000

Cash From Investing

67392000

Cash From Financing

0

Net Change In Cash

30515000

PE

-

PB

1.5585004730054568

ROE

-11.212555580910518

ROA

-10.453890102989718

FCF

-73754000

Fcf Percent

-

Piotroski FScore

1

Health Score

43

Deep Value Investing Score

4.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

2

Net Net Investing Score

2.5

Quality Investing Score

2.5

Value Investing Score

4.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

55595000

Quarters > 0 > income Statement > operating Income

-55595000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-50610000

Quarters > 0 > income Statement > net Income

-50610000

Quarters > 0 > income Statement > eps

-0.8575785817165128

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

59015000

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-50531000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

4985000

Quarters > 0 > balance Sheet > cash

103335000

Quarters > 0 > balance Sheet > short Term Investments

229261000

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

342235000

Quarters > 0 > balance Sheet > property Plant Equipment

1535000

Quarters > 0 > balance Sheet > total Assets

484126000

Quarters > 0 > balance Sheet > payables

1722000

Quarters > 0 > balance Sheet > short Term Debt

1188000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

32757000

Quarters > 0 > balance Sheet > equity

451369000

Quarters > 0 > cash Flow > net Income

-50610000

Quarters > 0 > cash Flow > depreciation

79000

Quarters > 0 > cash Flow > change In Working Capital

5545000

Quarters > 0 > cash Flow > cash From Operations

-36877000

Quarters > 0 > cash Flow > capital Expenditures

36877000

Quarters > 0 > cash Flow > cash From Investing

67392000

Quarters > 0 > cash Flow > cash From Financing

0

Quarters > 0 > cash Flow > net Change In Cash

30515000

Quarters > 0 > ratios > PE

-0.8575785817165128

Quarters > 0 > ratios > PB

1.5585004730054568

Quarters > 0 > ratios > ROE

-11.212555580910518

Quarters > 0 > ratios > ROA

-10.453890102989718

Quarters > 0 > ratios > FCF

-73754000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

43

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

77000

Quarters > 1 > income Statement > gross Profit

-77000

Quarters > 1 > income Statement > operating Expenses

75798000

Quarters > 1 > income Statement > operating Income

-75798000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-70055000

Quarters > 1 > income Statement > net Income

-70055000

Quarters > 1 > income Statement > eps

-1.1870710836228078

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

59015000

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-75721000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

5743000

Quarters > 1 > balance Sheet > cash

72820000

Quarters > 1 > balance Sheet > short Term Investments

192662000

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

275911000

Quarters > 1 > balance Sheet > property Plant Equipment

1749000

Quarters > 1 > balance Sheet > total Assets

520329000

Quarters > 1 > balance Sheet > payables

2461000

Quarters > 1 > balance Sheet > short Term Debt

1394000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

28183000

Quarters > 1 > balance Sheet > equity

492146000

Quarters > 1 > cash Flow > net Income

-70055000

Quarters > 1 > cash Flow > depreciation

77000

Quarters > 1 > cash Flow > change In Working Capital

4188000

Quarters > 1 > cash Flow > cash From Operations

-57609000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

53401000

Quarters > 1 > cash Flow > cash From Financing

373000

Quarters > 1 > cash Flow > net Change In Cash

-3835000

Quarters > 1 > ratios > PE

-1.1870710836228078

Quarters > 1 > ratios > PB

1.4293701462574115

Quarters > 1 > ratios > ROE

-14.234597050468764

Quarters > 1 > ratios > ROA

-13.463597070315128

Quarters > 1 > ratios > FCF

-57609000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

43

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

76000

Quarters > 2 > income Statement > gross Profit

-76000

Quarters > 2 > income Statement > operating Expenses

54996000

Quarters > 2 > income Statement > operating Income

-54996000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-48501000

Quarters > 2 > income Statement > net Income

-48501000

Quarters > 2 > income Statement > eps

-0.8233766233766234

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

58905000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-54920000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

6495000

Quarters > 2 > balance Sheet > cash

76655000

Quarters > 2 > balance Sheet > short Term Investments

227172000

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

317772000

Quarters > 2 > balance Sheet > property Plant Equipment

2157000

Quarters > 2 > balance Sheet > total Assets

579681000

Quarters > 2 > balance Sheet > payables

3401000

Quarters > 2 > balance Sheet > short Term Debt

1347000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

27842000

Quarters > 2 > balance Sheet > equity

551839000

Quarters > 2 > cash Flow > net Income

-48501000

Quarters > 2 > cash Flow > depreciation

76000

Quarters > 2 > cash Flow > change In Working Capital

-1793000

Quarters > 2 > cash Flow > cash From Operations

-43155000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

36805000

Quarters > 2 > cash Flow > cash From Financing

0

Quarters > 2 > cash Flow > net Change In Cash

-6350000

Quarters > 2 > ratios > PE

-0.8233766233766234

Quarters > 2 > ratios > PB

1.2723776318817628

Quarters > 2 > ratios > ROE

-8.788976494955957

Quarters > 2 > ratios > ROA

-8.366843143039016

Quarters > 2 > ratios > FCF

-43155000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

43

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

77000

Quarters > 3 > income Statement > gross Profit

-77000

Quarters > 3 > income Statement > operating Expenses

55048000

Quarters > 3 > income Statement > operating Income

-55048000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-47530000

Quarters > 3 > income Statement > net Income

-47647000

Quarters > 3 > income Statement > eps

-0.8133663366336633

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

58580000

Quarters > 3 > income Statement > income Tax Expense

117000

Quarters > 3 > income Statement > EBITDA

-54971000

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

7518000

Quarters > 3 > balance Sheet > cash

83005000

Quarters > 3 > balance Sheet > short Term Investments

315972000

Quarters > 3 > balance Sheet > receivables

3000000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

414668000

Quarters > 3 > balance Sheet > property Plant Equipment

2350000

Quarters > 3 > balance Sheet > total Assets

621824000

Quarters > 3 > balance Sheet > payables

1682000

Quarters > 3 > balance Sheet > short Term Debt

1302000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

31496000

Quarters > 3 > balance Sheet > equity

590328000

Quarters > 3 > cash Flow > net Income

-47647000

Quarters > 3 > cash Flow > depreciation

77000

Quarters > 3 > cash Flow > change In Working Capital

4821000

Quarters > 3 > cash Flow > cash From Operations

-36626000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

15964000

Quarters > 3 > cash Flow > cash From Financing

1582000

Quarters > 3 > cash Flow > net Change In Cash

-19080000

Quarters > 3 > ratios > PE

-0.8133663366336633

Quarters > 3 > ratios > PB

1.1828569879795638

Quarters > 3 > ratios > ROE

-8.071275629819356

Quarters > 3 > ratios > ROA

-7.662457544256895

Quarters > 3 > ratios > FCF

-36626000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

43

Valuation > metrics > PE

-0.8575785817165128

Valuation > metrics > PB

1.5585004730054568

Valuation > final Score

80

Valuation > verdict

Fair

Profitability > metrics > ROE

-11.212555580910518

Profitability > metrics > ROA

-14.788084211141467

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.07257255150442321

Risk > metrics > Interest Coverage

-703.7341772151899

Risk > final Score

-2755

Risk > verdict

High

Liquidity > metrics > Current Ratio

117.606529209622

Liquidity > metrics > Quick Ratio

117.606529209622

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

80

Prev Valuations > 2

80

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

15

Prev Risks > 0

6

Prev Risks > 1

26

Prev Risks > 2

30

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:19:49.709Z